DSIP (Delta Sleep-Inducing Peptide)

When to stay put vs. adjust

Stay put at 100 mcg before bed for the first week. DSIP effects are subtle — deeper feel to sleep, fewer wake-ups, more vivid dreams in some users — not a knockout effect like a sedative. Track sleep with a wearable if you have one; subjective impression alone is unreliable for sleep-architecture changes.

Consider stepping to 200–300 mcg only after at least one week at 100 mcg with no perceived effect. DSIP doesn't show a clear linear dose-response in the published studies, so escalating may or may not help — it's worth trying once if the lower dose did nothing.

Don't dose too early or too late. The ~7-minute half-life means the peptide is essentially gone within 30–60 minutes of injection. Inject too early (2+ hours before sleep) and you've missed the window. Inject too late (after you're already trying to sleep) and the effect lands during the wrong sleep phase. The 30–60 minutes before bed window is where the published protocols cluster.

Cycle off at the 2–4 week mark for 2–4 weeks. Tolerance build-up is reported with continuous use — the effect blunts over time. Cycling resets receptor sensitivity. This is one of the few peptides where the cycle-off rationale isn't conservative-just-in-case but is actually reported in user experience.

Watch for vivid or unsettling dreams, mild morning grogginess, or sleep fragmentation. The vivid-dreams effect is common and usually neutral-to-positive; the grogginess is usually a sign the dose is too high or timing is off. DSIP isn't a sedative, so morning grogginess is unexpected and worth reducing dose for.

Pair with sleep hygiene, not in place of it. The most-evidenced sleep interventions remain the basics — consistent schedule, dark cool room, no late caffeine, stress management, no screens before bed. People who haven't dialed in the fundamentals see less from DSIP than those who have. The peptide is at most an adjunct.

The honest read. The original 1970s/80s DSIP research is real but methodologically dated and produced mixed results. Modern controlled trials are essentially absent. Subjective community reports are common but DSIP is the kind of compound where placebo and ritual effects are hard to separate from peptide effects on something as variable as sleep. The biology is plausible — DSIP appears endogenously during slow-wave sleep — but injecting synthetic DSIP and getting reliable sleep-architecture improvements in healthy adults isn't well-established. If you don't notice a clear effect after a couple of weeks at 200–300 mcg, it's reasonable to conclude this isn't your peptide and move on.